Suzan Wetzels

Post doc

Dr Suzan Wetzels graduated from Maastricht University with a specialisation in Cardiovascular Biology and Medicine. During her PhD, she investigated the role of advanced glycation endproducts in multiple sclerosis. This research was conducted at the Department of Internal Medicine at Maastricht University under the supervision of Prof. Casper Schalkwijk and Dr Kristiaan Wouters and at the Department of Immunology and Biochemistry at Hasselt University under the supervision of Prof. Jerome Hendriks and Dr Tim Vanmierlo.

After obtaining her PhD in 2019, Suzan Wetzels started to work as a post-doc at the Department of Pathology. Her research, under the supervision of Prof. Erik Biessen, aims to investigate the functional differences in monocyte function in young and aged individuals using a high content analysis based approach.


Department ofPathology
P. Debeyelaan 25, 6229 HX Maastricht 
PO box 5800, 6202 AZ Maastricht
Room number: 5.06
T: +31(0)43 387 46 30

  • 2021
    • Wauters, L., Slaets, H., De Paepe, K., Ceulemans, M., Wetzels, S., Geboers, K., Toth, J., Thys, W., Dybajlo, R., Walgraeve, D., Biessen, E., Verbeke, K., Tack, J., Van de Wiele, T., Hellings, N., & Vanuytsel, T. (2021). Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trial. The Lancet Gastroenterology and Hepatology, 6(10), 784-792.
    • van Dongen, K. C. W., Linkens, A. M. A., Wetzels, S. M. W., Wouters, K., Vanmierlo, T., van de Waarenburg, M. P. H., Scheijen, J. L. J. M., de Vos, W. M., Belzer, C., & Schalkwijk, C. G. (2021). Dietary advanced glycation endproducts (AGEs) increase their concentration in plasma and tissues, result in inflammation and modulate gut microbial composition in mice; evidence for reversibility. Food Research International, 147, [110547].
  • 2020
    • Wouters, E., Grajchen, E., Jorissen, W., Dierckx, T., Wetzels, S., Loix, M., Tulleners, M. P., Staels, B., Stinissen, P., Haidar, M., Bogie, J. F. J., & Hendriks, J. J. A. (2020). Altered PPARγ Expression Promotes Myelin-Induced Foam Cell Formation in Macrophages in Multiple Sclerosis. International Journal of Molecular Sciences, 21(23), [9329].
    • Chteinberg, E., Wetzels, S., Gerritsen, W., Temmerman, L., van den Oord, J., Biessen, E., Kurz, A. K., Winnepenninckx, V., Zenke, M., Speel, E-J., & Hausen, A. Z. (2020). Navitoclax combined with Alpelisib effectively inhibits Merkel cell carcinoma cell growth in vitro. Therapeutic Advances in Medical Oncology, 12, [1758835920975621].
    • Wouters, K., Kusters, Y. H. A. M., Bijnen, M., Wetzels, S., Zhang, X., Linssen, P. B. C., Gaens, K., Houben, A. J. H. M., Joris, P. J., Plat, J., Kooi, M. E., van der Kallen, C. J. H., Mensink, R. P., Verboven, K., Jocken, J., Hansen, D., Blaak, E. E., Ehlers, F. A. I., Wieten, L., ... Schalkwijk, C. G. (2020). NK cells in human visceral adipose tissue contribute to obesity-associated insulin resistance through low-grade inflammation. Clinical and Translational Medicine, 10(6), [192].
    • Wetzels - van Hooijdonk, S., Bijnen, M., Wijnands, E., van de Gaar, M. J., Tan, A., Coort, S., Biessen, E., Schalkwijk, C., & Wouters, K. (2020). CD11c−MHC2low Macrophages Are a New Inflammatory and Dynamic Subset in Murine Adipose Tissue. Immunometabolism, 2(2), [e200015].
  • 2019
    • Wetzels, S., Vanmierlo, T., Scheijen, J. L. J. M., van Horssen, J., Amor, S., Somers, V., Schalkwijk, C. G., Hendriks, J. J. A., & Wouters, K. (2019). Methylglyoxal-Derived Advanced Glycation Endproducts Accumulate in Multiple Sclerosis Lesions. Frontiers in Immunology, 10, [855].
  • 2018
    • Bijnen, M., Beelen, N., Wetzels, S., van De Gaar, J., Vroomen, M., Wijnands, E., Scheijen, J. L., van de Waarenburg, M. P. H., Gijbels, M. J., Cleutjens, J. P., Biessen, E. A. L., Stehouwer, C. D. A., Schalkwijk, C. G., & Wouters, K. (2018). RAGE deficiency does not affect non-alcoholic steatohepatitis and atherosclerosis in Western type diet-fed Ldlr(-/-) mice. Scientific Reports, 8, [15256].
    • Wetzels, S., Wouters, K., Miyata, T., Scheijen, J. L. J. M., Hendriks, J. J. A., Schalkwijk, C. G., & Vanmierlo, T. (2018). Advanced Glycation Endproducts Are Increased in the Animal Model of Multiple Sclerosis but Cannot Be Reduced by Pyridoxamine Treatment or Glyoxalase 1 Overexpression. International journal of molecular sciences, 19(5), [1311].